These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11113777)

  • 41. Breast cancer facts.
    J Okla State Med Assoc; 2012 Oct; 105(10):411-2. PubMed ID: 23316677
    [No Abstract]   [Full Text] [Related]  

  • 42. Tamoxifen infrequently used by women at risk for breast cancer.
    Dreyfuss JH
    CA Cancer J Clin; 2010; 60(4):204-6. PubMed ID: 20530798
    [No Abstract]   [Full Text] [Related]  

  • 43. Summaries for patients. Using medications to decrease the risk for breast cancer in women: recommendations from the U.S. Preventive Services Task Force.
    Ann Intern Med; 2013 Nov; 159(10):I-28. PubMed ID: 24400336
    [No Abstract]   [Full Text] [Related]  

  • 44. Reaping the benefits of designer estrogens.
    Johns Hopkins Med Lett Health After 50; 1999 Nov; 11(9):6-7. PubMed ID: 10530089
    [No Abstract]   [Full Text] [Related]  

  • 45. Breast cancer risk reduction: strategies for women at increased risk.
    Chlebowski RT
    Annu Rev Med; 2002; 53():519-40. PubMed ID: 11818488
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Owens DK; Davidson KW; Krist AH; Barry MJ; Cabana M; Caughey AB; Doubeni CA; Epling JW; Kubik M; Landefeld CS; Mangione CM; Pbert L; Silverstein M; Tseng CW; Wong JB
    JAMA; 2019 Sep; 322(9):857-867. PubMed ID: 31479144
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lowering your breast cancer risk. A daily pill can hold the key to prevention for some women.
    Johns Hopkins Med Lett Health After 50; 2014 Feb; 25(15):1-2. PubMed ID: 25118364
    [No Abstract]   [Full Text] [Related]  

  • 48. Chemoprevention of breast cancer. A joint guideline from the Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative's Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.
    Levine M; Moutquin JM; Walton R; Feightner J;
    CMAJ; 2001 Jun; 164(12):1681-90. PubMed ID: 11450210
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention.
    Freedman AN; Graubard BI; Rao SR; McCaskill-Stevens W; Ballard-Barbash R; Gail MH
    J Natl Cancer Inst; 2003 Apr; 95(7):526-32. PubMed ID: 12671020
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk-benefit profiles of raloxifene for women.
    Stefanick ML
    N Engl J Med; 2006 Jul; 355(2):190-2. PubMed ID: 16837684
    [No Abstract]   [Full Text] [Related]  

  • 51. Long-term raloxifene in a woman at high risk for breast cancer.
    Bean GR; Kimler BF; Seewaldt VL
    N Engl J Med; 2006 Oct; 355(15):1620-2. PubMed ID: 17035661
    [No Abstract]   [Full Text] [Related]  

  • 52. Should We Offer Medication to Reduce Breast Cancer Risk?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
    Burns RB; Schonberg MA; Tung NM; Libman H
    Ann Intern Med; 2016 Aug; 165(3):194-204. PubMed ID: 27479221
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Breast cancer risk assessment, prevention, and the future.
    Green VL
    Obstet Gynecol Clin North Am; 2013 Sep; 40(3):525-49. PubMed ID: 24021255
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Toward optimal health: advances in breast cancer detection and management. Interview by Jodi R. Godfrey.
    Chlebowski RT
    J Womens Health (Larchmt); 2008 Sep; 17(7):1067-70. PubMed ID: 18774890
    [No Abstract]   [Full Text] [Related]  

  • 55. Independent assessment supports a role for tamoxifen in breast cancer risk reduction.
    Oncology (Williston Park); 1999 Sep; 13(9):1211. PubMed ID: 10509317
    [No Abstract]   [Full Text] [Related]  

  • 56. Breast cancer prevention.
    Euhus DM; Diaz J
    Breast J; 2015; 21(1):76-81. PubMed ID: 25413630
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Breast Cancer Prevention Trial is a raging success.
    Med Manag Netw; 1998 May; 6(5):5-7. PubMed ID: 10182972
    [No Abstract]   [Full Text] [Related]  

  • 58. Effects of tamoxifen and raloxifene on memory and other cognitive abilities: cognition in the study of tamoxifen and raloxifene.
    Legault C; Maki PM; Resnick SM; Coker L; Hogan P; Bevers TB; Shumaker SA
    J Clin Oncol; 2009 Nov; 27(31):5144-52. PubMed ID: 19770382
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.
    Gail MH; Costantino JP; Bryant J; Croyle R; Freedman L; Helzlsouer K; Vogel V
    J Natl Cancer Inst; 1999 Nov; 91(21):1829-46. PubMed ID: 10547390
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence of tamoxifen use for breast cancer chemoprevention among U.S. women.
    Waters EA; Cronin KA; Graubard BI; Han PK; Freedman AN
    Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):443-6. PubMed ID: 20142242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.